The Sanofi Genzyme Rare Diseases Medical Affairs team helps Healthcare Professionals (HCPs) make evidence-based decisions that optimize health outcomes for patients through the generation, dissemination, and interpretation of accurate clinical and scientific information about:
- Pompe disease
- Gaucher disease
- Fabry disease
- MPS I
- Acid sphingomyelinase deficiency (ASMD)
- Autosomal dominant polycystic kidney disease (ADPKD)
This website facilitates educational opportunities for HCPs through (1) web-based learning, and (2) informing of Scientific Education Programs conducted in collaboration with the Rare Diseases Medical Science Liaison (MSL) team.
The Rare Diseases MSL team supports Sanofi Genzyme’s pipeline and commercial products by delivering scientific information and education to HCPs, researchers, and payers with the ultimate goal of improved patient care.